Ningxia Zhongke Biotechnology Co., Ltd

SHSE:600165 Stock Report

Market Cap: CN¥1.3b

Ningxia Zhongke Biotechnology Balance Sheet Health

Financial Health criteria checks 2/6

Ningxia Zhongke Biotechnology has a total shareholder equity of CN¥-155.0M and total debt of CN¥1.2B, which brings its debt-to-equity ratio to -777.4%. Its total assets and total liabilities are CN¥2.2B and CN¥2.4B respectively.

Key information

-777.4%

Debt to equity ratio

CN¥1.21b

Debt

Interest coverage ration/a
CashCN¥96.76m
Equity-CN¥155.02m
Total liabilitiesCN¥2.37b
Total assetsCN¥2.21b

Recent financial health updates

No updates

Recent updates

Revenues Not Telling The Story For Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) After Shares Rise 25%

Nov 13
Revenues Not Telling The Story For Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) After Shares Rise 25%

What Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 34% Share Price Gain Is Not Telling You

Aug 30
What Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 34% Share Price Gain Is Not Telling You

Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Looks Just Right With A 50% Price Jump

Jul 12
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Looks Just Right With A 50% Price Jump

Calculating The Intrinsic Value Of Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165)

Jun 03
Calculating The Intrinsic Value Of Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165)

Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Apr 21
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Feb 27
Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Financial Position Analysis

Short Term Liabilities: 600165 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: 600165 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: 600165 has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: 600165's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 600165 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 600165 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34.1% per year.


Discover healthy companies